Ricevi le ultime notizie sulle azioni Vistagen Therapeutics con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di VTGN

Ultime notizie per

Vistagen Therapeutics

VistaGen Therapeutics

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Vistagen Therapeutics, Inc. - Common Stock

Vistagen Therapeutics Inc

Press Releases

Vistagen Reports Fiscal Year 2025 Financial Results and Provides Corporate Update

Vistagen Appoints Elissa Cote as Chief Corporate Development Officer

Vistagen Honored for Outstanding Workplace Culture and Mental Health Leadership

Vistagen to Present at the BTIG Virtual Biotechnology Conference

Vistagen to Report Fiscal Year 2026 First Quarter Results and Host Corporate Update Conference Call on August 7, 2025

Vistagen Reports Fiscal Year 2026 First Quarter Financial Results and Corporate Update

Vistagen to Present at the TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit

Vistagen to Present at The Menopause Society 2025 Annual Meeting

Vistagen Appoints Paul Edick to its Board of Directors

Vistagen Completes PALISADE-3 Phase 3 Public Speaking Challenge Study for the Acute Treatment of Social Anxiety Disorder

VTGN

Acumen Pharmaceuticals, Inc. - Common Stock

Acumen Pharmaceuticals

Alpha Cognition

Agenus

Alector

Anika Therapeutics

Anixa Biosciences

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech

Clene

Climb Bio

Coya Therapeutics

Citius Oncology

Entera Bio

Fate Therapeutics

Forte Biosciences

TuHURA Biosciences

Inhibikase Therapeutics, Inc. - Common Stock

Inhibikase Therapeutics

Immix Biopharma

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals

Opus Genetics

Seres Therapeutics

MDxHealth

NewAmsterdam Pharma Company N.V. - Warrant

NewAmsterdam Pharma Co

Sera Prognostics, Inc. - Class A Common Stock

Sera Prognostics

Spero Therapeutics

Tevogen Bio Holdings

Jefferies

Stifel

Maxim Group

Comments

Vistagen Therapeutics Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO